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sera (m±SD: 789±211 vs 501±98 OD ×1000; p<0.0001). At the same
time kOA patients had signiﬁcantly higher serum EM-IgG levels: 71% AII
(m±SD: 409±111 vs 274±84; p<0.0005), 59% VEGF (m±SD: 669±241 vs
471±189; p<0.0003), 35% bFGF (m±SD: 689±245 vs 455±115; p<0.009).
Serum BK-IgG overexpression in kOA patients were positively associated
with destructive changes (K&L>4; r=0.75; p<0.005). kOA patients in whom
K&L scores progress rapidly tend to have higher serum BK-IgG levels at all
time point. Elevated serum BK-IgG level was signiﬁcantly correlated with
enhanced pain (r=0.85; p<0.0001) and loss of functions (r=0.69; p<0.0003)
in kOA patients. At the same time kOA patients had signiﬁcantly lower
serum EM-IgM levels relative to normal sera: 66% AII (m±SD: 289±99 vs
455±101; p<0.0001), 79% VEGF (m±SD: 366±181 vs 559±198; p<0.005),
61% bFGF (m±SD: 521±222 vs 705±239; p<0.007). No signiﬁcant differ-
ence in binding of serum EM-IgA levels in kOA patients in comparison with
that in control. No correlations were found to conventional parameters for
pain and function with expression of EM-IgA, EM-IgM.
Conclusions: We showed that our ELISA was able to demonstrate immune
responses to each of the 4 type speciﬁc self-antigens in kOA patients. EM
represent a group of novel selfantigens which are targeted by NA from kOA
patients. Serum NA proﬁling is a promising approach for early detection
and diagnosis of kOA.This results show a speciﬁc dysbalance of Ig content
in kOA patients. Circulating BK-IgG in the sera has been proposed as a
sensitive and speciﬁc marker of diagnosing kOA at early stages of the
disease. Our results have potential applications for controlling unwanted
angiogenesis, inﬂammation, infection, pain and future response to therapy
in kOA patients.
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Purpose: Extracellular release of High Mobility Group Box 1 (HMGB1) may
exert pro-inﬂammatory activity in rheumatoid arthritis. However, the role
of HMGB1 during the progression of synovitis in osteoarthritis (OA) re-
mains unclear. We have recently demonstrated that IL-1β induces HMGB1
secretion by OA synoviocytes, suggesting the contribution of HMGB1 to
the pro-inﬂammatory effects elicited by IL-1β. In this study, we have
evaluated the effects of HMGB1 in OA synovitis and the signaling pathways
involved.
Methods: Synovial tissue samples were obtained from 15 OA patients
undergoing total knee joint replacement and 3 normal donors. HMGB1
expression was determined in both normal and OA human synovium by
immunohistochemistry and confocal microscopic procedures. OA synovio-
cytes were treated with human recombinant HMGB1 (15-25 ng/ml) in
presence or absence of IL-1 β (10 ng/ml). Gene expression was analyzed
by quantitative PCR and protein expression by Western Blot and ELISA.
MMP activity was determined by ﬂuorometric procedures and activation of
NF-κB by magnetic transfection of the reporter construct NF-κB-luc.
Results: Despite HMGB1 distribution in both normal and OA synovium
was similar (lining, sublining and vascular wall cells), the number of
HMGB1 positive cells was higher in OA, though it was also present in
inﬁltrated cells. Regarding to HMGB1 intracellular localization, we observed
that HMGB1 was mostly found in the nucleus of normal synovium cells,
whereas in OA the localization was markedly cytoplasmic. Treatment of
synoviocytes with 15 or 25 ng/ml of HMGB1 did not modify the production
of IL-6, IL-8, CCL2, CCL20 and matrix metalloproteinases (MMP)-1, 3 and
13). However, the concomitant treatment of HMGB1 with IL-1β signiﬁ-
cantly enhanced, in a dose dependent manner, both mRNA and protein
expression of these mediators, as well as MMP-activity. In addition, HMGB1
potentiated the phosphorylation of Akt, ERK 1/2 and p38 induced by IL-1β
as well as NF-κB activation.
Conclusions: Synovial HMGB1 expression is higher in OA, with a marked
cytoplasmic localization. HMGB1 can act in synergy with IL-1β, with the
consequent increase in the production of several pro-inﬂammatory and
degenerative mediators, thus contributing to synovitis progression during
OA.
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Purpose: Knee osteoarthritis (OA) is a major cause of pain and functional
disability among older people. People with knee OA tend to modify their
walking pattern to reduce pain and joint load. In addition, patients with OA
are characterised by increased inﬂammation and sensitised nerves, result-
ing in increased pain. It is unclear however if the increase in inﬂammatory
markers is related to gait characteristics, particularly knee function during
walking. The aim of this study was to examine the association between
inﬂammatory markers and pain, gait and functional parameters in people
with severe knee OA.
Methods: Nineteen patients (mean ± SEM, age 69.9±1.5 year and BMI
=29.9±0.9 kg·m-2) with severe knee OA scheduled for knee replacement
surgery participated in the study. Knee sagittal motion and moments
during walking were measured using three dimensional motion analysis
system (Vicon). The physical function, pain and stiffness were assessed
using the Western Ontario and McMaster University Osteoarthritis In-
dex. The pain level during walking and the physical activity were also
recorded using Visual analog scale (VAS 0-100mm) and The Incidental
and Planned Activity Questionnaire respectively. Muscle samples from the
vastus lateralis were taken from patients with knee OA during their knee
replacement surgery. Real-time PCR (RT-PCR) was performed to measure
the mRNA abundance of the pro-inﬂammatory cytokines; MCP-1, TNF-α,
IL-1β. The association between peak knee ﬂexion and extension motion
and moments during the stance phase of walking, pain, function and
physical activity was assessed using Pearson correlation coeﬃcient. Seven-
teen age-matched asymptomatic (MA) older people (age= 66.7±1.8 year,
BMI=29.8±1.2 kg·m-2) were used to compare gene analysis data.
Results: OA patients had signiﬁcantly greater mRNA levels of the pro-
inﬂammatory cytokines MCP-1 and TNF-α compared to MA individuals.
OA also tended to have higher levels of IL-1β compared to MA individ-
uals. Increases in pain were correlated with increases in atrogin-1 and
MCP1 (r=0.46, p=0.03; r=0.43, p=0.04, respectively). Increases in planned
physical activity was correlated with MCP-1 (r=0.46, p=0.03) and IL-1β
(r=0.43, p=0.04). TNF-α and IL-1β were signiﬁcantly correlated with peak
knee extension (r=0.54, p=0.01, r=-0.60, p≤0.001, respectively) and ﬂexion
moments (r= -0.56, p≤0.001; r=-0.49, p=0.02 respectively). Increase in IL-1β
mRNA expression was also correlated with reduced knee ﬂexion motion
during stance (r=-0.41, p=0.040. Moreover, MCP-1 was correlated with peak
knee extension moment (r=-0.50, p=0.02).
Conclusions: There is an association between increased inﬂammatory
markers and increase in pain and physical activity. Further, the results
indicate that lower knee ﬂexion moment and larger knee extension mo-
ments were correlated with increase in the inﬂammatory markers. This
gait pattern suggests that people with knee OA tend to reduce the load
over the knee joint by reducing their knee ﬂexion motion in an attempt
to minimise quadriceps use. While a causal relationship has not been
established, the unloading pattern may be a compensatory strategy related
to the presence of inﬂammatory markers. Investigation of the muscle
breakdown biomarkers is needed to better understand their role in muscle
function during walking in people with knee OA.
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Purpose: Anatomic features have been used to distinguish between trau-
